MedPath

Correlation Between Vitamin D Status and Bone Mineral Density in Patients With Hemophilia

Not Applicable
Completed
Conditions
Hemophilia A
Hemophilia B
Vitamin D Deficiency
Interventions
Dietary Supplement: Vitamin D and calcium
Registration Number
NCT01090206
Lead Sponsor
Virginia Commonwealth University
Brief Summary

Study will look at baseline Vitamin D levels, calcium, albumin, liver enzymes, testosterone, osteocalcin, urine N telopeptides, bone mineral density, nutritional assessment and physical activity assessment of boys with hemophilia A or B (ages 2-20 yrs). Patients with low vitamin D levels will receive therapeutic doses of Vitamin D. At end of one year follow up studies will be repeated.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
20
Inclusion Criteria
  • clinical diagnosis of Hemophilia A or B
  • ages 2-21 years
Exclusion Criteria
  • therapeutic vitamin D or calcium supplementation within 3 months of study entry

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Hemophilia, Vitamin D deficiencyVitamin D and calcium1. Hemophilia, Rickets - Vitamin D per endocrine consult 2. Hemophilia, Vitamin D deficient - Vitamin D 2000 units daily plus calcium 3. Hemophilia, Normal Vitamin D - no intervention - observation only
Primary Outcome Measures
NameTimeMethod
Correlate between Vitamin D deficiency, low bone mass and lack of weight bearing physical activity1year
Secondary Outcome Measures
NameTimeMethod
Determine bone mass (density) in hemophilia patients1 yr
establish dose and duration of treatment with vitamin D1 yr

Trial Locations

Locations (1)

Virginia Commonwealth University Health System

🇺🇸

Richmond, Virginia, United States

© Copyright 2025. All Rights Reserved by MedPath